Skip to main content

HomePEG-MGFLegal status

Educational — Not Legal AdviceReviewed

Is PEG-MGF legal? FDA status and US regulatory standing

Current status

Compounding nomination withdrawn. PEG-MGF was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists.

Primary source: www.fda.gov

Federal legal status

FDA approval status

PEG-MGF was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists. PEGylated IGF-1 splice variant with extended half-life. No FDA approval. WADA prohibited. Not on any FDA list. Sold as research chemical. No NDA or IND.

Also known as

Pegylated Mechano Growth Factor · PEGylated MGF

Frequently asked questions

Is PEG-MGF FDA approved?
PEG-MGF was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists. Primary source linked on this page.
Is PEG-MGF legal to buy?
PEG-MGF is available in the U.S. as a research-use-only compound. It was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists. Sale for human consumption is not permitted.
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

peptidebase.io
The Independent Peptide Database

Independent peptide intelligence.No sponsored placements.

Prices, providers, and published evidence — tracked independently, never an affiliate code. Get research updates as the data grows.

8,600+
price changes tracked
1,200+
peer-reviewed citations
0
paid placements

Free · occasional research updates only · unsubscribe in one click

Already a member? Sign in